Cargando…
Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer
BACKGROUND: Early detection of colorectal cancer (CRC) is essential to reduce cancer-related morbidity and mortality. Stool DNA (sDNA) testing is an emerging method for early CRC detection. Syndecan-2 (SDC2) methylation is a potential biomarker for the sDNA testing. Aberrant DNA methylation is an ea...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600770/ https://www.ncbi.nlm.nih.gov/pubmed/37901726 http://dx.doi.org/10.4240/wjgs.v15.i9.2032 |
_version_ | 1785126058316529664 |
---|---|
author | Song, Ji Hyeong Oh, Tae Jeong An, Sungwhan Lee, Kyung Ha Kim, Ji Yeon Kim, Jin Soo |
author_facet | Song, Ji Hyeong Oh, Tae Jeong An, Sungwhan Lee, Kyung Ha Kim, Ji Yeon Kim, Jin Soo |
author_sort | Song, Ji Hyeong |
collection | PubMed |
description | BACKGROUND: Early detection of colorectal cancer (CRC) is essential to reduce cancer-related morbidity and mortality. Stool DNA (sDNA) testing is an emerging method for early CRC detection. Syndecan-2 (SDC2) methylation is a potential biomarker for the sDNA testing. Aberrant DNA methylation is an early epigenetic event during tumorigenesis and can occur in the normal colonic mucosa during aging, which can compromise the sDNA test results. AIM: To determine whether methylated SDC2 in sDNA normalizes after surgical resection of CRC. METHODS: In this prospective study, we enrolled 151 patients with CRC who underwent curative surgical resection between September 2016 and May 2020. Preoperative stool samples were collected from 123 patients and postoperative samples were collected from 122 patients. A total of 104 samples were collected from both preoperative and postoperative patients. Aberrant promoter methylation of SDC2 in sDNA was assessed using linear target enrichment quantitative methylation-specific real-time polymerase chain reaction. Clinicopathological parameters were analyzed using the results of SDC2 methylation. RESULTS: Detection rates of SDC2 methylation in the preoperative and postoperative stool samples were 88.6% and 19.7%, respectively. Large tumor size (3 cm, P = 0.019) and advanced T stage (T3–T4, P = 0.033) were positively associated with the detection rate of SDC2 methylation before surgery. Female sex was associated with false positives after surgery (P = 0.030). Cycle threshold (C(T)) values were significantly decreased postoperatively compared with preoperative values (P < 0.001). The postoperative negative conversion rate for preoperatively methylated SDC2 was 79.3% (73/92). CONCLUSION: Our results suggested that the SDC2 methylation test for sDNA has acceptable sensitivity and specificity. However, small size and early T stage tumors are associated with a low detection rate of SDC2 methylation. As the cycle threshold values significantly decreased after surgery, SDC2 methylation test for sDNA might have a diagnostic value for CRC. |
format | Online Article Text |
id | pubmed-10600770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-106007702023-10-27 Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer Song, Ji Hyeong Oh, Tae Jeong An, Sungwhan Lee, Kyung Ha Kim, Ji Yeon Kim, Jin Soo World J Gastrointest Surg Observational Study BACKGROUND: Early detection of colorectal cancer (CRC) is essential to reduce cancer-related morbidity and mortality. Stool DNA (sDNA) testing is an emerging method for early CRC detection. Syndecan-2 (SDC2) methylation is a potential biomarker for the sDNA testing. Aberrant DNA methylation is an early epigenetic event during tumorigenesis and can occur in the normal colonic mucosa during aging, which can compromise the sDNA test results. AIM: To determine whether methylated SDC2 in sDNA normalizes after surgical resection of CRC. METHODS: In this prospective study, we enrolled 151 patients with CRC who underwent curative surgical resection between September 2016 and May 2020. Preoperative stool samples were collected from 123 patients and postoperative samples were collected from 122 patients. A total of 104 samples were collected from both preoperative and postoperative patients. Aberrant promoter methylation of SDC2 in sDNA was assessed using linear target enrichment quantitative methylation-specific real-time polymerase chain reaction. Clinicopathological parameters were analyzed using the results of SDC2 methylation. RESULTS: Detection rates of SDC2 methylation in the preoperative and postoperative stool samples were 88.6% and 19.7%, respectively. Large tumor size (3 cm, P = 0.019) and advanced T stage (T3–T4, P = 0.033) were positively associated with the detection rate of SDC2 methylation before surgery. Female sex was associated with false positives after surgery (P = 0.030). Cycle threshold (C(T)) values were significantly decreased postoperatively compared with preoperative values (P < 0.001). The postoperative negative conversion rate for preoperatively methylated SDC2 was 79.3% (73/92). CONCLUSION: Our results suggested that the SDC2 methylation test for sDNA has acceptable sensitivity and specificity. However, small size and early T stage tumors are associated with a low detection rate of SDC2 methylation. As the cycle threshold values significantly decreased after surgery, SDC2 methylation test for sDNA might have a diagnostic value for CRC. Baishideng Publishing Group Inc 2023-09-27 2023-09-27 /pmc/articles/PMC10600770/ /pubmed/37901726 http://dx.doi.org/10.4240/wjgs.v15.i9.2032 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Observational Study Song, Ji Hyeong Oh, Tae Jeong An, Sungwhan Lee, Kyung Ha Kim, Ji Yeon Kim, Jin Soo Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer |
title | Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer |
title_full | Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer |
title_fullStr | Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer |
title_full_unstemmed | Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer |
title_short | Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer |
title_sort | comparative detection of syndecan-2 methylation in preoperative and postoperative stool dna in patients with colorectal cancer |
topic | Observational Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600770/ https://www.ncbi.nlm.nih.gov/pubmed/37901726 http://dx.doi.org/10.4240/wjgs.v15.i9.2032 |
work_keys_str_mv | AT songjihyeong comparativedetectionofsyndecan2methylationinpreoperativeandpostoperativestooldnainpatientswithcolorectalcancer AT ohtaejeong comparativedetectionofsyndecan2methylationinpreoperativeandpostoperativestooldnainpatientswithcolorectalcancer AT ansungwhan comparativedetectionofsyndecan2methylationinpreoperativeandpostoperativestooldnainpatientswithcolorectalcancer AT leekyungha comparativedetectionofsyndecan2methylationinpreoperativeandpostoperativestooldnainpatientswithcolorectalcancer AT kimjiyeon comparativedetectionofsyndecan2methylationinpreoperativeandpostoperativestooldnainpatientswithcolorectalcancer AT kimjinsoo comparativedetectionofsyndecan2methylationinpreoperativeandpostoperativestooldnainpatientswithcolorectalcancer |